Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 4 of 11
  1. Fasinumab

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. Febuxostat XR

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. Febuxostat XR 80 mg Capsule F1

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. Fucoidan (extract of Laminaria japonica)

    Takeda

    Healthy Volunteers

    phase 1 other completed

    1 trial
  5. GC4419

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. GC4419 IV

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. GC4711 30 mg IV

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. GC4711 Oral Capsule G-101

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. GLA-AF

    Lxo Ireland Designated Activity Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. GSBR-1290

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. GSBR-1290 (Capsule/Tablet)

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  12. Glyburide

    United Therapeutics Europe Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. HD204

    Prestige Biopharma Belgium

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. HYQVIA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. Human butyrylcholinesterase (HuBChE) derived from human plasma

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  16. Hydromorphone 16 mg

    Janssen Cilag International NV

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. INFS (Intranasal Fentanyl Spray)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. INO-A002

    INOVIO PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 mab completed

    1 trial
  19. ION547

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. ION904

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. IP

    Nurix Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  22. ITI-333

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  23. IW-3300

    IRONWOOD PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  24. Insulin Peglispro

    Eli Lilly and Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.